Brilliant Violet 421TM anti-human CD107a (LAMP-1) [H4A3]
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0448230
- Awardee
- BIOLEGEND INC.
- Contracting organization
- University of Virginia
- Cumulative value
- $297.00
About this award
The University of Virginia awarded contract A207_PO-0448230 to BioLegend Inc. on June 12, 2026, for the procurement of laboratory reagents and research materials. The prime contractor will deliver Brilliant Violet 421 anti-human CD107a (LAMP-1) [H4A3], a monoclonal antibody reagent commonly used in flow cytometry and immunological research applications. The contract is valued at $297 and consists of a single line item for one unit of the specified product.
Delivery of the reagent is designated to Martha Joy Macdonald Spano at the University of Virginia in Virginia. This contract represents a routine procurement of specialized research materials by an academic institution from a commercial supplier of life science reagents and antibodies. The relatively modest contract value reflects the purchase of a single unit of a specialized laboratory reagent for use in the university's research operations.
Line items
| Item | Total |
|---|---|
| Brilliant Violet 421TM anti-human CD107a (LAMP-1) [H4A3] | $297.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0448230?
Contract A207_PO-0448230 was awarded to BIOLEGEND INC. by University of Virginia on June 12, 2026.
How much is contract A207_PO-0448230 worth?
Its cumulative value is $297.00.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award